BIO
Bio-Rad Laboratories Inc
NYSE: BIO · HEALTHCARE · MEDICAL DEVICES
$327.25
-1.13% today
Updated 2026-07-29
Market cap
$8.08B
P/E ratio
50.32
P/S ratio
3.15x
EPS (TTM)
$6.00
Dividend yield
—
52W range
$237 – $343
Volume
0.4M
Bio-Rad Laboratories Inc (BIO) Financial Forecast & Price Target 2030
Revenue-driven projection model with historical context.
Price target summary
Current price
$327.25
12-Month target
$271.22
2030 Target
—
Intrinsic (DCF)
$198.00
Financial forecast
| Metric | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Revenue | $2.9B | $2.8B | $2.7B | $2.6B | $2.6B |
| EPS | — | — | — | — | — |
CAGR applied: — (capped 20%) · P/E: 25.00x (capped 25x) · Margin: 6.52%
Methodology
CAGR-based projection model. Research-backed estimates are being generated — check back soon for analyst consensus and management guidance.